Status:
COMPLETED
Minimal Clinically Important Changes in Osteoarthritis Treatment
Lead Sponsor:
Joint Academy
Collaborating Sponsors:
Lund University
Conditions:
Osteoarthritis, Knee
Osteoarthritis, Hip
Eligibility:
All Genders
18+ years
Brief Summary
To assess minimal clinically important change, cut-offs for treatment failure and patient acceptable symptom state for pain and patient-reported function and quality of life in persons with hip or kne...
Detailed Description
Patient-reported outcome measures (PROMs) are consistently recommended as the primary end-point in clinical trials evaluating treatment effects in different medical conditions. For a meaningful interp...
Eligibility Criteria
Inclusion
- Data for all participants enrolled in the program until May 2022, and have given their written informed consent, will be extracted from the digital treatment register.
- Inclusion criteria will be; i) diagnosed hip or knee OA ii) provided answer for KOOS/HOOS questionnaires and/or NRS pain at baseline and any of the follow-ups, i.e., 3, 6, 9 and/or 12 months.
- Exclusion criteria: none
Exclusion
Key Trial Info
Start Date :
June 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
11708 Patients enrolled
Trial Details
Trial ID
NCT05316194
Start Date
June 6 2018
End Date
July 1 2021
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthro Therapeutics
Malmo, Sweden, 21134